1. Home
  2. OPI vs LUCD Comparison

OPI vs LUCD Comparison

Compare OPI & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPI
  • LUCD
  • Stock Information
  • Founded
  • OPI 2009
  • LUCD 2018
  • Country
  • OPI United States
  • LUCD United States
  • Employees
  • OPI N/A
  • LUCD N/A
  • Industry
  • OPI Real Estate Investment Trusts
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • OPI Real Estate
  • LUCD Health Care
  • Exchange
  • OPI Nasdaq
  • LUCD Nasdaq
  • Market Cap
  • OPI 63.9M
  • LUCD 51.6M
  • IPO Year
  • OPI 2009
  • LUCD 2021
  • Fundamental
  • Price
  • OPI $0.87
  • LUCD $1.46
  • Analyst Decision
  • OPI Buy
  • LUCD Strong Buy
  • Analyst Count
  • OPI 2
  • LUCD 4
  • Target Price
  • OPI $4.30
  • LUCD $3.63
  • AVG Volume (30 Days)
  • OPI 465.3K
  • LUCD 680.2K
  • Earning Date
  • OPI 02-13-2025
  • LUCD 03-24-2025
  • Dividend Yield
  • OPI 4.59%
  • LUCD N/A
  • EPS Growth
  • OPI N/A
  • LUCD N/A
  • EPS
  • OPI N/A
  • LUCD N/A
  • Revenue
  • OPI $501,979,000.00
  • LUCD $4,189,000.00
  • Revenue This Year
  • OPI N/A
  • LUCD $91.72
  • Revenue Next Year
  • OPI N/A
  • LUCD $139.38
  • P/E Ratio
  • OPI N/A
  • LUCD N/A
  • Revenue Growth
  • OPI N/A
  • LUCD 179.27
  • 52 Week Low
  • OPI $0.84
  • LUCD $0.63
  • 52 Week High
  • OPI $3.20
  • LUCD $1.63
  • Technical
  • Relative Strength Index (RSI)
  • OPI 38.42
  • LUCD 73.16
  • Support Level
  • OPI $0.84
  • LUCD $1.34
  • Resistance Level
  • OPI $0.99
  • LUCD $1.63
  • Average True Range (ATR)
  • OPI 0.05
  • LUCD 0.14
  • MACD
  • OPI -0.00
  • LUCD 0.04
  • Stochastic Oscillator
  • OPI 15.38
  • LUCD 76.87

About OPI Office Properties Income Trust of Beneficial Interest

Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its largest tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: